Proxy Statement

BioCardia, Inc. Filed 2020-12-02 Acc 0001437749-20-024669

Documents 1

2021-04-30 DEF 14A Proxy Statement
2020-12-02 DEF 14A Proxy Statement
2020-12-01 4 President and CEO bought 4,200 shares at an average $2.40 ($10,068)
2020-12-01 8-K Regulation FD disclosure
2019-10-15 DEF 14A Proxy Statement

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading bcda20201201_def14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…